Plasma copeptin levels in the patients with gastrointestinal bleeding

Area of Science:

• Biochemistry
• Gastroenterology
• Emergency Medicine

Background:

• Gastrointestinal bleeding (GIB) is a major global health concern, causing significant morbidity, mortality, and healthcare costs.
• Understanding the etiology and location of GIB is crucial for effective patient management.
• Biomarkers that can rapidly assess GIB are needed in emergency settings.

Purpose of the Study:

• To investigate the relationship between plasma copeptin levels and the etiology, location, and severity of gastrointestinal bleeding.
• To evaluate the potential utility of copeptin as a diagnostic marker in acute GIB.

Main Methods:

• Prospective study of 104 consecutive emergency department patients with symptoms of GIB.
• Measurement of plasma copeptin levels at admission (0 hours) and at 12 and 24 hours.
• Comparison of copeptin levels with etiological factors, bleeding location, and severity using statistical analysis.

Main Results:

• Plasma copeptin levels were not significantly different across various etiologies of gastrointestinal bleeding.
• No statistically significant differences were observed in copeptin levels at 0, 12, or 24 hours between patient groups.
• A trend suggested higher copeptin levels in patients with peptic ulcers, but this was not statistically significant.

Conclusions:

• Plasma copeptin is not a reliable biomarker for determining the etiology or location of gastrointestinal bleeding in the emergency department.
• Copeptin may have a role in guiding decisions related to endoscopy and patient hospitalization for suspected GIB.
• Further research is needed to fully elucidate the role of copeptin in managing gastrointestinal bleeding.